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Abstract
Advances in human immunodeficiency virus (HIV) therapy with highly active 
antiretroviral agents has increased the longevity of patients afflicted with this disease. 
HIV vasculopathy is a unique disease entity presenting as aneurysms, dissections and 
vascular occlusion amongst others due to HIV related vasculitis. A few studies have 
investigated the pathogenesis of HIV related vasculopathy. This chapter provides a brief 
overview of aortic aneurysms in general. Further, the current understanding of the 
pathogenic mechanisms underlying HIV vasculopathy with an emphasis on inflam-
matory mediators, histology, clinical presentation and imaging are discussed. Finally, a 
summary regarding management of HIV associated large vessel disease is presented.
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1. Introduction
Human immunodeficiency virus (HIV) is a global disease. According to global HIV 
and acquired immunodeficiency syndrome (AIDS) statistics in 2017, there were 36.9 
Figure 1. 
Structure of the mature HIV virus. (Reproduced from Ref. [2]. Permission obtained from Michael S. Pepper).
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million [31.1–43.9 million] people living with HIV, of whom 35.1 million [29.6–41.7 
million] adults. The majority of these individuals reside in the developing world [1].
HIV infection involves multiple systems including the cardiovascular system. A 
structure of the HIV virus and its replication in a cell are depicted in Figures 1 and 2. 
A large number of these patients present with vascular pathology [3, 4]. HIV afflicts 
the vascular system in multiple ways. Patients may present with a diverse array of 
aneurysms, occlusive disease, spontaneous arteriovenous fistulae and dissections. 
The precise pathogenesis of HIV related vasculitis remains poorly understood, a few 
recent studies have tried to address this issue [5].
In this chapter we will review the current knowledge pertaining to the important 
entity of HIV associated vasculopathy with an emphasis on effects of HIV on the aorta.
2. Definition and broad overview of aortic aneurysms
An aortic aneurysm is a dilation of a segment of the aortic wall, which may 
undergo further expansion and rupture [6]. It is defined as at least a 50% increase 
in diameter compared with the expected normal diameter of the vessel. They may 
occur in the ascending or the descending thoracic or abdominal aorta.
It may be fusiform or saccular in morphology [6]. A fusiform aneurysm is charac-
terised by a uniform symmetric enlargement of the entire circumference of the aortic 
wall. A saccular aneurysm involves dilation of a localised portion of the aortic wall.
Figure 2. 
Diagram illustrating HIV replication. (A) The virus glycoprotein receptors bind to host cell CD4 and a 
co-receptor CCR5. (B) Fusion of the virus with the host cell membrane results in viral uncoating and the release 
of the viral nucleocapsid into the cytoplasm. (C) The enzyme reverse transcriptase converts the single stranded 
RNA into double stranded DNA. (D) The viral DNA is transported to the host nucleus where it is integrated 
into the host’s DNA. (E) Viral DNA is transcribed and translated using host cell machinery and then cleaved 
by viral protease into functional viral proteins. (F) Viral RNA and proteins assemble at the cell surface and 
bud off the cellular membrane. (Reproduced from Ref. [2]. Permission obtained from Michael S Pepper).
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These are true aneurysms as opposed to false aneurysms, as they involve all three 
layers of the aortic wall.
3. Aetiology
There are multiple aetiologies implicated in the pathogenesis of aortic aneurysms [6].
These include:
1. Degenerative or atherosclerotic diseases.
2. Genetic diseases, such as Marfan syndrome, Loeys-Dietz syndrome, Ehlers-
Danlos syndrome, familial thoracic aortic aneurysms, bicuspid aortic valve dis-
ease, Turner syndrome and aortopathy associated with congenital heart disease.
3. Inflammatory diseases, such as Takayasu’s disease and giant cell arteritis.
4. Infectious diseases, including bacterial infections (the most common organ-
isms implicated are Staphylococcus aureus, Salmonella species, Escherichia coli, 
Streptococcus species, Neisseria species and gram-negative bacilli) and fungi. 
Recently, HIV has been implicated in the pathogenesis of aortic aneurysms. 
Infected aortic aneurysms have a high mortality.
4. Epidemiology
The true incidence and prevalence of aortic aneurysms is difficult to ascertain 
due to the silent nature of this disease [7]. In a computed chest tomography (CT) 
study the prevalence of asymptomatic thoracic ascending aneurysm was 0.16% 
[8]. In a different study the prevalence was noted to be 0.34% [9]. The incidence 
and prevalence of aneurysms tend to differ between studies due to different aortic 
dimension cut-offs. The majority of studies did not include aortas between 4 and 
5 cm [7]. The annual incidence according to two studies was estimated to be in the 
range of 5.6 and 10.4 cases per 100,000 patient-years [10, 11]. Thoracic aneurysms 
are more common in men greater than 60 years of age [7].
Abdominal aortic aneurysm is predominantly a disease of men [12–15]. The 
incidence rises with age. In screening studies its prevalence is estimated at 4–8%. 
The incidence of new cases of abdominal aortic aneurysms in the western popula-
tion is estimated at 0.4–0.67% [7].
The true incidence and prevalence of HIV associated aneurysms remains 
understudied. The incidence of symptomatic vasculitis in HIV-infected patients is 
reported to be 1% [16].
5. Pathogenesis of HIV associated vasculopathy
The pathogenesis of HIV associated vasculopathy is multifactorial (Figure 3) 
[5]. Three pathophysiological processes have been implicated:
• Inflammation and endothelial injury
• Smooth muscle cell proliferation and migration
• Molecular mimicry
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5.1 Inflammation and endothelial injury
Endothelial cell dysfunction as a result of increase in inflammatory mediators to 
viral proteins has been implicated in the pathogenesis of HIV related vasculitis [5]. 
The inflammatory mediators include interleukins 1, 6 and 8, and tumour necrosis 
factor-alpha. The aforementioned argument is supported by a study by Nieuwhof 
et al., in the setting of cerebral vasculitis, whereby, they found an increased CD25-
positive receptor positive T-cells. HIV envelope surface glycoprotein 120 and a 
transactivator transcription protein that have been implicated in the stimulation of 
pro-inflammatory pathways in HIV related vasculitis.
Increased oxidative stress in HIV in animal studies has been proposed as an 
additional mechanism of endothelial dysfunction [17].
5.2 Smooth muscle cell proliferation and migration
Smooth muscle cells, an important component of the muscularis media, possess 
important surface receptors such as CD4, CCR5 and CXCR4 [5]. These receptors 
mediate the entry of HIV virus into the cell resulting in invasion and disruption of 
tunica media, and activation of tissue factor 2 with resultant stimulation of pro-
coagulant pathways.
5.3 Molecular mimicry
It is theorised that the arterial wall possesses receptors known as matrix adhe-
sion molecule-1 which may share ligands with similar deoxyribonucleic acid 
sequences to those present in the viral envelope glycoprotein, GP41 and GP120 [5]. 
This may result in an autoimmune response within the host and cell damage.
5.4  Other postulated mechanisms involved in the pathogenesis of HIV related 
vasculopathy
Direct invasion by HIV of vascular endothelium and toxicities related to highly 
active antiretroviral therapy (HAART) have been postulated as possible additional 
mechanisms resulting in endothelial injury [17].
Figure 3. 
Pathogenesis of HIV associated vasculopathy. (Reproduced from Ref. [5]. Permission obtained from B Pillay).
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5.5 HIV-associated aortopathy
HIV-associated aortopathy may present as aneurysmal disease of the ascending 
and the descending aorta (Figure 4a–d). Bacterial infections have been implicated 
in the pathogenesis of aortic aneurysms [5, 6]. A few case reports have reported the 
presence of Salmonella-related mycotic aneurysmal disease in HIV-positive patients. 
These aneurysms have been reported in immunosuppressed patients with advanced 
HIV disease [5].
5.6 Other forms of HIV related vasculopathy
HIV may affect femoral, carotid and popliteal arteries [5]. It may manifest as 
aneurysmal or occlusive disease as well as present as arterio-venous fistula and 
as arterial dissection. Since the advent of HAART, atherosclerotic disease is also a 
possible manifestation of HIV vasculopathy.
6.  Histopathological features of HIV associated large vessel 
vasculopathy
Large vessel vasculopathy related to HIV is characterised by involvement of all 
three layers of the vessel wall [5]. There is infiltration of the vasa vasorum, periad-
ventitial vessels and the adventitia by leucocytes. The media demonstrates fibrosis, 
muscle damage and elastin fragmentation. The intima also is characterised by 
disrupted internal elastic lamina and calcification.
Intracranial aneurysms due to HIV have been reported in children [5]. 
Overall histopathological studies have shown similar microscopic characteristics 
as previously described. Some studies, however, have shown distinct tissue 
characteristics in arteries of patients with intracranial aneurysms. These include 
variable absence of internal elastic lamina fragmentation, medial thickening 
with sub-intimal SMC deposition, presence of viral protein gp41 within the 
Figure 4. 
Two and three dimensional long axis trans-oesophageal images of an enlarged ascending aorta in a patient 
with HIV associated aortopathy (arrow) (a, b) and a normal aorta in a control (arrow) (c, d).
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macrophages of the arterial wall, as well as identification of agents such as 
varicella zoster virus in the tissue.
7. Clinical features of HIV-associated large vessel vasculopathy
These patients will usually have stigmata of advanced HIV disease and presence 
of other opportunistic infections may confound the clinical picture.
The majority of patients with thoracic ascending aortic aneurysms and abdomi-
nal aortic aneurysms are asymptomatic [5, 18]. Symptoms usually result from large 
aneurysms and include chest or upper back pain, or with symptoms related to 
compression of nearby structures leading to nerve dysfunction, or compression of 
the artery resulting in limb ischemia or thromboembolism. The initial presentation 
may be aortic dissection or rupture and is associated with high mortality.
Abdominal aortic aneurysms may present with abdominal, back, or flank pain, 
thromboembolism or limb ischemia [19].
An enlarging aneurysm of the carotid artery may present with dysphagia, air-
way compromise, hoarse voice, cranial nerve involvement, cerebrovascular accident 
and even rupture [5].
Occlusive disease is another manifestation of HIV vasculopathy [5]. It usually 
involves young males below the age of 40 years. It afflicts lower limbs more commonly 
than upper limbs. Clinical presentation can be acute or chronic. Acute presentation 
involves arterial thrombosis or occlusion. Chronic disease may manifest as critical limb 
ischemia in the form of rest pain or gangrene in more than half of the patients.
8. Imaging in HIV associated vasculopathy
A basic chest radiograph is considered a reasonable initial test in a patient pre-
senting with chest pain. It can exclude an alternative diagnosis and avoid unneces-
sary additional aortic imaging [18].
A transthoracic echocardiogram or transesophageal echocardiography are useful 
bedside tests to assess the presence of aortic enlargement and related complications 
such as aortic regurgitation, dissection and pericardial effusion.
Cardiac computed tomography and magnetic resonance angiography are the 
imaging modalities of choice and help determine the aortic size, branch vessel 
anatomy and presence of dissection (Figure 5) [18]. In patients with coexisting risk 
factors for coronary artery disease such as HIV, a cardiac CT is useful to exclude 
presence of coronary artery disease.
Digital subtraction arteriography provides higher resolution of lumen of the 
vessel and is better at evaluating branch vessel pathology [18].
The aortic measurements must be made at the aortic annulus, sinuses, sinotubu-
lar junction, ascending arch, and specific locations of the descending aorta as per 
the American society of echocardiography chamber quantification guidelines [20]. 
The aortic annulus is measured at peak systole whereas all other aortic dimensions 
are measured at end-diastole. Currently, a leading edge to leading edge method of 
measurement is recommended.
Large vessel disease has been studied with the aid of multiple imaging modalities. 
Arterial inflammation in patients with HIV has been demonstrated using 18flourode-
oxyglucose-positron emission tomography [21]. Inflammation is associated with an 
increased cardiovascular risk amongst HIV patients. Carotid intima-media thickness 
has been studied in these patients with the aid of ultrasound technology [22]. An 
increased carotid intima thickness is a marker of adverse cardiovascular disease.
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The choice of imaging technique depends on the availability of resources and 
expertise to interpret the results of the test.
9. Management of patients with HIV vasculopathy
Currently all HIV patients with vascular disease must be managed according to 
standard guidelines [23]. Conservative management may be considered in a moribund 
severely immunosuppressed patient with multiple co-morbidities [5]. All patients 
must be on HAART therapy.
Data regarding management of ascending aortic aneurysm in patients with HIV is 
limited. Currently the standard guidelines on management of aortopathy are applied 
to these patients. Patients with ascending thoracic aortic aneurysms with symptoms 
due to aortic regurgitation, dissection and rupture should undergo emergent surgery as 
per the standard guidelines [23]. Those without symptoms but an enlarged ascending 
aorta greater than 55 mm are at high risk of rupture and dissection and therefore urgent 
surgery is recommended. Asymptomatic patients who display rapid growth of thoraco-
abdominal aortic aneurysms, expansion ≥1 cm per year for aneurysms less than 50 mm 
in diameter, must undergo surgery [24]. Aortic diameter is an important risk factor for 
aneurysm rupture, dissection and mortality [6]. An ascending aorta diameter of 6.0 
and 7.0 cm in the descending aorta is associated with increased risk of rupture.
In patients with multiple comorbidities and high risk for surgery conservative 
management with afterload reducing agents such as angiotensin converting enzyme 
inhibitors or angiotensin receptor antagonists, can be utilised to reduce the shear 
stress on the aorta and prevent further expansion and dissection [6, 25]. Beta block-
ers have been shown to decrease aortic stress and are recommended even in patients 
without systemic hypertension [6].
In centres where there is a lack of expertise in managing thoracic aortic disease, 
patients should be referred to an appropriate high volume centre in order to provide 
the best care and outcomes for such patients [25].
For descending aortic and peripheral artery aneurysms, depending on the site 
and location of the aneurysm patients can undergo surgical repair of the aneurysm 
with good success [5]. Patients that are unable to tolerate major surgery due to poor 
Figure 5. 
Transthoracic echocardiographic suprasternal views of an enlarged aortic arch (right) and descending thoracic 
aorta dissection (left) in a patient with HIV.
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physiologic reserve can be offered endovascular repair. Data comparing endovascu-
lar repair versus surgery are limited in patients with HIV. Descending aortic aneu-
rysms depending on the size and in absence of complications can be managed with 
medical therapy under close observation and follow-up [6].
The medical management of patients with HIV-related vasculopathy involves a 
combination of HAART, treatment of hyperlipidaemia and control of traditional 
risk factors associated with cardiovascular disease [5].
10. Prognosis and outcome
HIV patients with low CD4 counts, hyperglobulinemia, hypoalbuminemia and 
reversed CD4/CD8 ratios were reported have worse prognosis in a study by Van Marle 
et al. [26]. For peripheral large vessel surgery the perioperative mortality was reported 
to be between 9 and 10.6% in South Africa and 33% in Houston [5]. Major challenges 
related to wound healing and infection. Late graft sepsis rate of 10% has been reported 
with the use of prosthetic grafts. The follow-up in the aforementioned studies was poor 
and presents a major challenge in reporting long term outcomes. Further, the results 
may vary between patients on HAART compared to those without HAART. There 
are no studies pertaining to surgery in patients with ascending aortic aneurysms and 
descending thoracic aneurysms in the setting of HIV. No current studies address the 
natural history of HIV associated ascending or descending aortic aneurysms.
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